Defective apoptotic cell clearance in asthma and COPD

a new drug target for statins?

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Asthma and chronic obstructive pulmonary disease represent increasingly common respiratory conditions with a clear unmet need for more effective and safer therapy. Airway inflammation is key to both asthma pathogenesis and exacerbations of symptoms in chronic obstructive pulmonary disease. Several lines of evidence are now emerging implicating the increased persistence of apoptotic cells in patients with chronic inflammatory lung diseases and that this is largely due to a combination of inhibition of, or defects in, the apoptotic process and/or impaired apoptotic cell removal mechanisms.
Original languageEnglish
Pages (from-to)6-11
Number of pages6
JournalTrends in Pharmacological Sciences
Volume29
Issue number1
Early online date4 Dec 2007
DOIs
Publication statusPublished - Jan 2008

Keywords

  • Anti-Asthmatic Agents
  • Apoptosis
  • Asthma
  • Drug Delivery Systems
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pulmonary Disease, Chronic Obstructive

Cite this

Defective apoptotic cell clearance in asthma and COPD : a new drug target for statins? / Walsh, Garry Michael.

In: Trends in Pharmacological Sciences, Vol. 29, No. 1, 01.2008, p. 6-11.

Research output: Contribution to journalArticle

@article{e2c95b2653454e94b8e3a10dd2907493,
title = "Defective apoptotic cell clearance in asthma and COPD: a new drug target for statins?",
abstract = "Asthma and chronic obstructive pulmonary disease represent increasingly common respiratory conditions with a clear unmet need for more effective and safer therapy. Airway inflammation is key to both asthma pathogenesis and exacerbations of symptoms in chronic obstructive pulmonary disease. Several lines of evidence are now emerging implicating the increased persistence of apoptotic cells in patients with chronic inflammatory lung diseases and that this is largely due to a combination of inhibition of, or defects in, the apoptotic process and/or impaired apoptotic cell removal mechanisms.",
keywords = "Anti-Asthmatic Agents, Apoptosis, Asthma, Drug Delivery Systems, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Pulmonary Disease, Chronic Obstructive",
author = "Walsh, {Garry Michael}",
year = "2008",
month = "1",
doi = "10.1016/j.tips.2007.11.002",
language = "English",
volume = "29",
pages = "6--11",
journal = "Trends in Pharmacological Sciences",
issn = "0165-6147",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Defective apoptotic cell clearance in asthma and COPD

T2 - a new drug target for statins?

AU - Walsh, Garry Michael

PY - 2008/1

Y1 - 2008/1

N2 - Asthma and chronic obstructive pulmonary disease represent increasingly common respiratory conditions with a clear unmet need for more effective and safer therapy. Airway inflammation is key to both asthma pathogenesis and exacerbations of symptoms in chronic obstructive pulmonary disease. Several lines of evidence are now emerging implicating the increased persistence of apoptotic cells in patients with chronic inflammatory lung diseases and that this is largely due to a combination of inhibition of, or defects in, the apoptotic process and/or impaired apoptotic cell removal mechanisms.

AB - Asthma and chronic obstructive pulmonary disease represent increasingly common respiratory conditions with a clear unmet need for more effective and safer therapy. Airway inflammation is key to both asthma pathogenesis and exacerbations of symptoms in chronic obstructive pulmonary disease. Several lines of evidence are now emerging implicating the increased persistence of apoptotic cells in patients with chronic inflammatory lung diseases and that this is largely due to a combination of inhibition of, or defects in, the apoptotic process and/or impaired apoptotic cell removal mechanisms.

KW - Anti-Asthmatic Agents

KW - Apoptosis

KW - Asthma

KW - Drug Delivery Systems

KW - Humans

KW - Hydroxymethylglutaryl-CoA Reductase Inhibitors

KW - Pulmonary Disease, Chronic Obstructive

U2 - 10.1016/j.tips.2007.11.002

DO - 10.1016/j.tips.2007.11.002

M3 - Article

VL - 29

SP - 6

EP - 11

JO - Trends in Pharmacological Sciences

JF - Trends in Pharmacological Sciences

SN - 0165-6147

IS - 1

ER -